371 related articles for article (PubMed ID: 17712416)
1. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes.
Palmqvist L; Pineault N; Wasslavik C; Humphries RK
PLoS One; 2007 Aug; 2(8):e768. PubMed ID: 17712416
[TBL] [Abstract][Full Text] [Related]
2. Hox genes: from leukemia to hematopoietic stem cell expansion.
Abramovich C; Pineault N; Ohta H; Humphries RK
Ann N Y Acad Sci; 2005 Jun; 1044():109-16. PubMed ID: 15958703
[TBL] [Abstract][Full Text] [Related]
3. Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3.
Argiropoulos B; Palmqvist L; Yung E; Kuchenbauer F; Heuser M; Sly LM; Wan A; Krystal G; Humphries RK
Exp Hematol; 2008 Jul; 36(7):845-59. PubMed ID: 18375036
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
5. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
6. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
Hirose K; Abramovich C; Argiropoulos B; Humphries RK
Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
[TBL] [Abstract][Full Text] [Related]
7. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
Calvo KR; Sykes DB; Pasillas MP; Kamps MP
Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
[TBL] [Abstract][Full Text] [Related]
8. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.
Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK
Blood; 2003 Jun; 101(11):4529-38. PubMed ID: 12543865
[TBL] [Abstract][Full Text] [Related]
9. Brief report: ectopic expression of NUP98-HOXA10 augments erythroid differentiation of human embryonic stem cells.
Ji J; Risueño RM; Hong S; Allan D; Rosten P; Humphries K; Bhatia M
Stem Cells; 2011 Apr; 29(4):736-41. PubMed ID: 21328509
[TBL] [Abstract][Full Text] [Related]
10. Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA.
Pineault N; Abramovich C; Humphries RK
Leukemia; 2005 Apr; 19(4):636-43. PubMed ID: 15744344
[TBL] [Abstract][Full Text] [Related]
11. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia.
Palmqvist L; Argiropoulos B; Pineault N; Abramovich C; Sly LM; Krystal G; Wan A; Humphries RK
Blood; 2006 Aug; 108(3):1030-6. PubMed ID: 16861351
[TBL] [Abstract][Full Text] [Related]
12. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
Pineault N; Abramovich C; Ohta H; Humphries RK
Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
[TBL] [Abstract][Full Text] [Related]
13. Ontogeny stage-independent and high-level clonal expansion in vitro of mouse hematopoietic stem cells stimulated by an engineered NUP98-HOX fusion transcription factor.
Sekulovic S; Gasparetto M; Lecault V; Hoesli CA; Kent DG; Rosten P; Wan A; Brookes C; Hansen CL; Piret JM; Smith C; Eaves CJ; Humphries RK
Blood; 2011 Oct; 118(16):4366-76. PubMed ID: 21865344
[TBL] [Abstract][Full Text] [Related]
14. High level in vitro expansion of murine hematopoietic stem cells.
Sekulovic S; Imren S; Humphries K
Curr Protoc Stem Cell Biol; 2008 Jan; Chapter 2():Unit 2A.7. PubMed ID: 18770636
[TBL] [Abstract][Full Text] [Related]
15. NUP98 dysregulation in myeloid leukemogenesis.
Moore MA; Chung KY; Plasilova M; Schuringa JJ; Shieh JH; Zhou P; Morrone G
Ann N Y Acad Sci; 2007 Jun; 1106():114-42. PubMed ID: 17442773
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of immune system via immortal bone marrow stem cells.
Ruedl C; Khameneh HJ; Karjalainen K
Int Immunol; 2008 Sep; 20(9):1211-8. PubMed ID: 18644831
[TBL] [Abstract][Full Text] [Related]
17. In-depth characterization of the microRNA transcriptome in a leukemia progression model.
Kuchenbauer F; Morin RD; Argiropoulos B; Petriv OI; Griffith M; Heuser M; Yung E; Piper J; Delaney A; Prabhu AL; Zhao Y; McDonald H; Zeng T; Hirst M; Hansen CL; Marra MA; Humphries RK
Genome Res; 2008 Nov; 18(11):1787-97. PubMed ID: 18849523
[TBL] [Abstract][Full Text] [Related]
18. HOXA4 induces expansion of hematopoietic stem cells in vitro and confers enhancement of pro-B-cells in vivo.
Fournier M; Lebert-Ghali CÉ; Krosl G; Bijl JJ
Stem Cells Dev; 2012 Jan; 21(1):133-42. PubMed ID: 21749220
[TBL] [Abstract][Full Text] [Related]
19. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.
Takeda A; Goolsby C; Yaseen NR
Cancer Res; 2006 Jul; 66(13):6628-37. PubMed ID: 16818636
[TBL] [Abstract][Full Text] [Related]
20. Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation.
Chung KY; Morrone G; Schuringa JJ; Plasilova M; Shieh JH; Zhang Y; Zhou P; Moore MA
Cancer Res; 2006 Dec; 66(24):11781-91. PubMed ID: 17178874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
